| 注册
首页|期刊导航|国际医药卫生导报|齐拉西酮治疗32例女性精神分裂症患者不良反应观察

齐拉西酮治疗32例女性精神分裂症患者不良反应观察

杨艳芬 裴树景 赵钊

国际医药卫生导报2013,Vol.19Issue(23):3567-3570,4.
国际医药卫生导报2013,Vol.19Issue(23):3567-3570,4.DOI:10.3760/cma.j.issn.1007-1245.2013.23.013

齐拉西酮治疗32例女性精神分裂症患者不良反应观察

The observation of adverse reactions of Ziprasidone in the treatment of 32 cases of female schizophrenia

杨艳芬 1裴树景 1赵钊1

作者信息

  • 1. 030800晋中,山西省荣军精神康宁医院女一区
  • 折叠

摘要

Abstract

Objective To discuss the safety of Ziprasidone in female schizophrenia patients.Methods 32 cases of female schizophrenia were treated with Ziprasidone for 6 weeks.Laboratory examination and ECG examination were carried out before and 2,4,6 weeks after treatment.Investigated the influence of Ziprasidone on lipid,blood glucose,body weight and ECG in female schizophrenia patients.Results The levels of triglyceride,cholesterol and body weight of female schizophrenia patients after treatment significantly rose than those before treatment,with statistical significant differences (P < 0.05); QT and QTC interval 4 weeks after treatment significantly prolonged,with statistical significant differences (P < 0.05).Conclusion Ziprasidone has influence on serum lipid,body weight and QT interval in female schizophrenic patients,but not on blood glucose.

关键词

齐拉西酮/精神分裂症/血糖/心电图/血脂/体重

Key words

Ziprasidone/ Schizophrenia/ Blood glucose/ ECG/ Serum lipid/ Body weight

引用本文复制引用

杨艳芬,裴树景,赵钊..齐拉西酮治疗32例女性精神分裂症患者不良反应观察[J].国际医药卫生导报,2013,19(23):3567-3570,4.

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文